Abstract: To test the hypothesis that increased circulating estradiol increases hepatic glutamine synthetase (GS) content in young and aged cows, and two nonclassical nongenomic estradiol pathway intermediates [β-catenin, G protein-coupled receptor 30 (GPR30)], 12 young (3-4 yr) and 12 aged (≥8 yr) cows were randomly allotted (n = 6) and received either none or estradiol (TRT) implants (Compudose®) for 28 d. Blood and liver samples were collected on days 16 and 28 and the effects of TRT, cow age (age), time after implant (day), and their interactions were analyzed by analysis of variance (ANOVA). Plasma estradiol was increased by TRT in young and aged cows on days 16 and 28 and on day 28 vs. day 16. An age × day interaction (P = 0.01) revealed lower GS mRNA at day 28 in young cows but increased mRNA in aged cows. Aged cows had less GS protein than young cows, and a TRT × day interaction (P = 0.02) reflected 134% more of GS on day 16 in TRT in aged cows. No main or interaction effects were found for progesterone, β-catenin, or GPR30. We conclude that hepatic GS expression is transiently stimulated by increased circulating estradiol, whereas expression of β-catenin or GPR30 was not affected. . Une interaction age × day (P = 0,01) a révélé de plus faibles niveaux d'ARNm de la GS au jour 28 chez les jeunes vaches, mais des niveaux plus élevés d'ARNm chez les vieilles vaches. Les vaches âgées avaient moins de protéine GS que les jeunes vaches et une interaction TRT × day (P = 0,02) reflétait une quantité 134 % plus grande de GS au jour 16 chez les vaches âgées TRT. Aucune interaction principale et aucun effet d'interaction n'a été observée pour la progestérone, la β-caténine, ou le GPR30. Nous concluons que l'expression hépatique de la GS est stimulée de façon transitoire par l'augmentation de l'estradiol circulant, tandis qu'il n'y a pas eu d'effet sur l'expression de la β-caténine ou le GPR30. [Traduit par la Rédaction] Mots-clés : vieillissement, β-caténine, boeufs, oestrogènes, récepteur 30 couplé à la protéine G (GPR30), glutamine synthétase.
Introduction
Beef cows (≥8 yr old) produce calves with lower birth and weaning weights (BIF 1996) and daughters with reduced milk yield and productive life spans (Baker and Boyd 2003; Fuerst-Waltl et al. 2004 ). The physiological mechanisms responsible for these aging-related effects are not understood. However, aging of mammals is associated with decreased hepatic expression and function of proteins responsible for intermediary metabolism (Schmucker 2005; Serste and Bourgeois 2006) , including decreased hepatic activity of glutamine synthetase (GS) in mice (Dhahbi et al. 1999) . Similarly, aged vs. young Angus cows managed under forage-and confinement-based management regimens have decreased hepatic expression of GS (52%-71%) (Miles et al. 2015) . Hepatic GS is expressed by pericentral hepatocytes and functions to incorporate sinusoidal ammonia that has escaped urea formation, into glutamine. Thus, GS activity represents an important source of peripheral glutamine and an important component of both the L-glutamine/L-glutamate hepatic cycle and whole-body N recycling (Watford 2000) . Recently, it was found that estradiol administration (Compudose® ear implant, 25.7 mg 17β-estradiol) to aged slaughter-house beef cows (>10 yr old), of unknown ancestry and consuming ad libitum amounts of alfalfa hay, had increased hepatic GS mRNA (60%) and protein (300%) content vs. nonimplanted cohorts (Miles et al. 2015) .
Estrogen-regulated cellular events can be divided into "classical/genomic" and "nonclassical/nongenomic" pathways. The classical genomic pathway involves transport of the ligand-bound α (ERα, a.k.a. ESR1) or β (ERβ, a.k.a. ESR2) estrogen receptors from the plasma membrane into the cell to promote nuclear transcription and (or) mediate nonnuclear cell signaling cascades (Eyster 2016) . The estradiol-bound receptors bind to the estrogen response element located on the promoter region of target genes or interact with other transcription factors (e.g., β-catenin) to initiate the transcription of target genes with no estrogen response elements present on the promoter region (Heldring et al. 2007 ). In the canonical Wnt/β-catenin pathway, Wnt signals by activating β-catenin for translocation into the nucleus (Kouzmenko et al. 2004) . Ligand binding (e.g., estradiol) of Wnt and LPR5/6 triggers the activation of β-catenin by inhibiting the β-catenin degradation complex (Songeregger et al. 2010) . The regulatory actions of Wnt allows for the nonphosphorylated form of β-catenin to dissociate from the degradation complex and bind to T-cell factor and other transcription factors for translocation into the nucleus to activate target genes. In the absence of Wnt activation, β-catenin is phosphorylated by GSK3β or casein kinase I and is targeted for ubiquitin-mediated degradation. Of note, the gene for GS (GLUL) contains a single T-cell factor/lymphoid enhancer that is required for responsiveness to β-catenin (Clinkenbeard et al. 2012) .
β-Catenin may be a modulator of estradiol stimulation of GS expression because of its additional reputed role in maintaining GS expression in pericentral hepatocytes (Burke and Tosh 2006) and because GS mRNA is upregulated in transgenic mice overexpressing hepatic β-catenin (Cadoret et al. 2002; Zucman et al. 2007 ). Estrogen receptor (ER) α and ERβ mRNA are expressed by the liver of cattle (Pfaffl et al. 2001) , whereas expression of β-catenin is unknown to the authors.
The nongenomic estrogen pathways include estrogen activation of the G protein-coupled receptor 30 (GPR30), a recently discovered membrane-bound plasma receptor thought to be a prime target in the activation of nongenomic regulation of target genes by estrogen (Prossnitz and Barton 2011) . Despite being less defined than estrogen interaction with ERα, ERβ, and β-catenin, estrogen binding of GPR30 (a.k.a. GPER) results in activation of the adenylyl cyclase, the phosphoinositol 3 kinase, and the phospholipase C pathways in several cell types (Albanito et al. 2007; Heldring et al. 2007 ) and human liver tissue (Hsieh et al. 2007 ). Moreover, evidence for cross talk between GPR30 and ERα has been accumulating (Sheng and Zhu 2011) . However, reports of GPR30 expression by cattle liver are unknown to the authors.
The overall goal of the present trial using Angus cows of known ages and pedigrees, and fed a corn silage-based diet to provide more than maintenance requirements, was to (1) determine if the same estradiol administration regimen affected GS expression in both young and aged cows of known ancestry (Angus) and (2) gain insight into potential activation of "nonclassical" estradiol pathways contributing to any putative changes. The specific hypotheses tested were that (1) estradiol administration would increase hepatic GS content in young as well as aged cows, (2) putative changes in hepatic GS mRNA content will parallel protein content, and (3) the expected increase in GS protein content will be accompanied by increased protein content of β-catenin, GPR30, or both.
Materials and Methods
All experimental animal procedures were approved by the University of Kentucky Institutional Animal Care and Use Committee.
Animals and diet
Twelve young (3-4 yr old) and 12 aged (8-12 yr old) Angus cows that were dry (≥4 mo) and open (≥9 mo) were used. Cows were housed in individual feeding pens (2.4 m × 14.6 m) at the University of Kentucky Agricultural Research Center, located in Woodford County, KY, USA. Beginning 7 d before study initiation, cows were acclimated to a diet consisting of 93.3% corn silage, 5.5% soybean meal, and 1.2% vitamin-mineral supplement [dry matter (DM) basis]. This diet was formulated to contain 10% crude protein on a DM basis and calculated to provide 1.3 × NE m requirements, where NE m is net energy for maintenance (NRC 1996) . Representative feed samples were collected twice a week by random grab sampling and pooled by week. Proximate and mineral analyses were performed (Dairy One Forage Laboratory, Ithaca, NY, USA) on pooled weekly samples (Table 1) . Cows had ad libitum access to water throughout the trial. Cows were fed daily at 0800. Full body weight (BW) was determined (before feeding) at days 0, 16, and 28, and BW change was calculated from BW difference between day 28 and day 0. The amount of diet fed was individually adjusted to BW after BW determination on days 0 and 16.
Estradiol and control implant treatments
Within an age group, cows were randomly allotted within BW rank to receive either a sham (control; 0.5 mg oxytetracycline) or estradiol (Compudose®; 25.7 mg 17β-estradiol plus 0.5 mg oxytetracycline; Vetlife, Des Moines, IA) implant treatment. Treatment groups were young control (n = 6; BW = 645 ± 26.5 kg; age = 3.26 ± 0.59 yr), young estradiol (n = 6; BW = 663 ± 21.7 kg; age = 2.90 ± 0.51 yr), aged control (n = 6; BW = 770 ± 20.4 kg; age = 11.48 ± 1.34 yr), and aged estradiol (n = 6; BW = 760 ± 17.5 kg; age = 9.86 ± 1.45 yr). Between estradiol treatment groups within an age, the mean age of cows did not differ (young, P = 0.801; aged, P = 0.811). The back of the left ear of all cows was clipped, cleansed with 70% ethyl alcohol solution, and dried. Control treatment cows received a subcutaneous sham implant of sterile corn oil and oxytetracycline (0.5 mg) in the dorsal-medial area, whereas estradiol treatment cows received the controlled-release estradiol implant (Compudose®) using a Compudose® Implanter (Vetlife).
Blood collection and fractionation
Jugular venous blood samples were collected by venipuncture on days 16 and 28. Sixteen milliliter of blood was collected in EDTA-containing (0.937 mg mL −1 ) vacutainers (Becton Dickinson, Franklin Lakes, NJ, USA), plasma recovered by refrigerated centrifugation at 3000g for 10 min at 4°C and then stored at −80°C.
Analysis of plasma hormones
Plasma estradiol was evaluated using the UltraSensitive Estradiol Radioimmunoassay kit (Diagnostic Systems Labs, Webster, TX, USA) as described (Miles et al. 2015) . The detection limit was 0.67 pg estradiol mL −1 and the intra-assay and inter-assay coefficient of variation (CV) were 7.1% and 11.9%, respectively.
Plasma progesterone levels were measured using the Coat-A-Count Progesterone 125 I Radioimmunoassay kit per manufacturer's instructions (Siemens Medical Solutions Diagnostics, Los Angeles, CA, USA). The sensitivity of this assay was 0.038 ng mL −1 , the intra-assay CV was 11%, and the interassay CV was 5%.
Liver tissue biopsy
Hepatic tissue was collected on days 16 and 28 by aspiration technique (Brennan et al. 2011) . The tissue was weighed and separated for RNA (400 mg wet tissue) and protein (200 mg wet tissue) extraction. Samples were placed in foil packs, snap frozen in liquid nitrogen, and stored at −80°C.
Immunoblot analysis
Biopsied liver tissue samples were homogenized and protein quantified as described (Miles et al. 2015) . Protein homogenates were separated by 12% SDS-PAGE under reducing conditions and electrotransferred to a 0.45 μm nitrocellulose membrane (BioRad, Hercules, CA, USA) using standard SDS-PAGE protocols (Howell et al. 2001) . Relative liver protein expression was determined using a general immunoblot regimen (Howell et al. 2001) . Relative contents of GS and GPR30 were evaluated using 60 μg of homogenized liver tissue/ lane, whereas β-catenin content was evaluated using 90 μg lane −1 .
To detect β-catenin, blots were hybridized with 14.5 μg of antichicken β-catenin (Abcam Inc., Cambridge, MA, USA) IgG, respectively, per milliliter of blocking solution [1. (Brown et al. 2008) . All protein-primary antibody binding reactions were visualized with a chemiluminescence kit (Pierce, Rockford, IL, USA) after hybridization of primary antibodies with horseradish peroxidase-conjugated goat antimouse IgG (BD Biosciences, San Jose, CA, USA; GS, 1:5000 and β-catenin, 1:10000) or horseradish peroxidase-conjugated goat antirabbit IgG (Abcam Inc.; GPR30, 1:5000).
The use of antisheep GS for cattle tissue has been described (Brown et al. 2008) . The use of the mouse monoclonal antichicken β-catenin against bovine β-catenin was justified given that Madin-Darby bovine kidney cell lysate is the positive control for this antibody (Abcam). When probed with the mouse monoclonal antichicken β-catenin and horseradish peroxidase-conjugated goat antimouse IgG pair (Fig. 1) , a proportional increase in a single immunoreaction product of M r of ∼94 kDa (consistent with Cui et al. 2014 ) was observed in response to increasing amounts of bovine liver tissue homogenates. Conversely, no immunoreaction products were found when homogenates were probed with only the horseradish peroxidase-conjugated goat antimouse IgG. The specificity of the human anti-GPR30 antibody against the putative bovine GPR30 was validated by antibody: antigen peptide prehybridization experiments (Xue et al. 2011 ) using homogenates of liver from young control cows (Fig. 2) . Two (40 and 50 kDa) GPR30 immunoreactive products were abolished with GPR30 antigen. These M r values are consistent with those reported for human and represent glycosylated and nonglycosylated forms of GPR30 (Chakrabarti and Davidge 2012; Jala et al. 2012) .
Densitometric analysis of immunoreactive products was performed as described (Xue et al. 2010) . Briefly, after exposure of autoradiographic film (Amersham), digital images of all observed immunoreactive species were recorded and quantified using the BioRad Versadoc imaging system and the Quantity One Program (version 4.2.3, BioRad). Data were collected as arbitrary densitometric units and then were corrected for unequal loading and (or) transfer of proteins by normalization to densitometric values of Fast-Green-stained (Fisher Scientific, Pittsburg, PA, USA) proteins common to all immunoblot lanes/samples. For all results, densitometric values were normalized to values found for day 16 young control cows, by obtaining an average young control densitometric value on 16 d and dividing all results by this value. Digital images were prepared with PowerPoint (Microsoft PowerPoint 2003, Bellevue, MA, USA).
Extraction of total RNA and relative real-time reversetranscriptase-polymerase chain reaction assay Purified RNA was extracted from biopsied liver tissue samples (approximately 200 mg), quality determined, and stored at −80°C as described . All RNA integrity numbers were greater than 8.0 and 28S/18S rRNA ratios greater than 1.8. Approximately 3 μg of crude RNA was treated with DNase I enzyme (amplification grade), reverse transcribed as described, and amplified using the standard relative curve method as described for both 18S rRNA (18S) and GS mRNA. Briefly, bovine liver total RNA was reverse transcribed; the cDNA sample was serially diluted 2.5×, 5×, 25×, 125×, 625×, 3 125×, 15 625×, 78 125×, and 390 625×; and the linear range for target mRNA quantification was established to ascertain an appropriate amount of cDNA to be used for a standard curve method. The primer-probe set for 18S was previously validated (Liao et al. 2008) . For GS (template GenBank accession no. NM_001040474.2), the forward primer, reverse primer, and TaqMan probe (forward) were 5′-CACG AATGCCGAGGTCATG-3′, 5′-CGATTCCTTCACAGGGT CCTATCT-3′, and 5′-six-carboxy-fluoresein-ACAGTG GGAATTCC-3′, respectively. The resulting GS cDNA was sequenced and was 100% identical to its template (data not shown).
For each cDNA sample, the real-time reverse transcription -polymerase chain reaction (RT-PCR) reactions were conducted in triplicate. The minimal threshold (CT) values detected using these dilutions were approximately 35 and 21 for GS and 18S cDNA, respectively, and the optimal detections of GS and 18S cDNA were achieved using 1:5 and 1:15625 dilutions of the RT product stocks, respectively. Potential age and estradiol treatment effect on expression of 18S RNA by the liver were evaluated by comparing the CT values obtained from the real-time PCR reactions (Applied Biosystems 2004). The CT values for 18S quantities and the calibrated values for age and estradiol treatment effect were subjected to their respective statistical analysis (see below) and found not to differ (P ≥ 0.657). Therefore, the relative quantity of GS mRNA expression was normalized to the relative 18S quantities by calculating the target gene:18S relative quantity ratios, and these 18S-normalized quantity ratios were used for estradiol treatment effect on GS mRNA expression. Ratios are expressed relative to the 18S-normalized ratio from the values found for day 16 control cows.
Statistical analysis
Individual cows were the experimental units. Data are presented as least-squares means (±SEM). The main effects of age (young vs. aged), estradiol treatment (TRT) (control vs. estradiol), and day (16 vs. 28), and their interactions, on all measured parameters except for BW and BW change were evaluated by analysis of variance (ANOVA), using the MIXED procedure of SAS version 8.01 (SAS Institute, Inc., Cary, NC, USA). DAY was included in the REPEATED statement, and cow was included in the random statement. Kenward-Roger adjustment was used to calculate the denominator df (Kenward and Roger 1997) . The main effects of age, TRT, and day on BW were analyzed as just described except that day included days 0, 16, and 28. The main effects of age and TRT on BW change were compared by ANOVA (SAS version 8.01). To further evaluate a TRT × day interaction for GS protein content, the SLICE option of the LSMEANS statement of SAS (version 9.4) was employed to partition the TRT × day interaction into separate days 16 and 28 components. To further evaluate an age × day interaction for GS mRNA content, the SLICE option was employed to partition the age × day interaction into separate young and aged cow components. For all analyses, statistical significance was declared when P ≤ 0.05, and tendency to differ was declared when 0.07 ≤ P > 0.05.
Results and Discussion

Aging cow model
Aging is associated with decreased expression of proteins responsible for intermediary metabolism in the liver (Serste and Bourgeois 2006) . Regarding the effect of aging on the hepatic L-glutamine/L-glutamate cycle, pericentral hepatocyte GS activity is decreased (21%) in the liver of aged rats (Danh et al. 1985) , consistent with decreased GS mRNA content in the liver of aged mice (Dhahbi et al. 1999; Spindler 2001) . In cattle, little information is known about the relationship between hepatic function and aging. However, the content of GS protein in the liver of aged (≥8 yr) cows is decreased by 46%-71% compared with that of young (3-5 yr) in the liver tissue of grazing and limit-fed Angus cows, respectively (Miles et al. 2015) . Importantly, estradiol administration (one-time Compudose® implants) to aged (≥10 yr) beef cows of unknown genetic backgrounds consuming alfalfa-hay-based diet ad libitum increased hepatic content of GS after 28 d (Miles et al. 2015) .
These findings are exciting because they demonstrate the potential applicability of estradiol supplementation in a typical, commercial beef cattle production regimen. However, not knowing the actual age, feed intake, and breed type allowed for the possibility of confounded or masked treatment effects. Therefore, the first goal of the present trial was to determine if the same estradiol supplementation regimen was repeatable in Angus cows of known ages, and pedigrees fed a corn silage-based diet to provide more than maintenance requirements (1.3 × NE m ; Table 1 ) and determine if estradiol treatment equally affected GS expression in young and aged cows.
Concentrations of estradiol and progesterone
Age did not affect (P = 0.34) plasma estradiol concentrations (Table 2) . However, plasma estradiol concentrations of estradiol-implanted cows were greater (P = 0.03) than those of control cows. A day effect (P < 0.01) was found, reflecting a higher plasma estradiol concentration for both estradiol treatment groups on day 28 vs. day 16. The increased concentration of estradiol in plasma in aged cows was expected (Miles et al. 2015) , whereas plasma estradiol concentrations for young cows implanted with Compudose® have not been reported to our knowledge.
In contrast to estradiol, plasma progesterone was not affected (P ≥ 0.29) by any main effects or their interactions, also as expected (Miles et al. 2015) .
BW change
The ability of supplemental estradiol (either alone or in combination with progesterone) to stimulate the efficiency of BW gain in heifers and cows has been well documented and reviewed (Reinhardt 2007) . Initial BW within each young and aged cow groups did not differ (P ≥ 0.628) between control and estradiol-administered cows. Over the experimental time period, BW was greater (P < 0.01) for aged than young cows and BW increased (P < 0.01) for both age groups (Table 3) . Cow BW was not affected by estradiol implantation (P = 0.69). In contrast, BW change was greater for both young (0.2 kg d −1 ) and aged (0.55 kg d −1 ) estradioladministered cows (Table 3) . However, the reader is cautioned that the number of observations for this measurement was low (n = 6), no measure of compositional gain (e.g., body condition scores) was made, and there was a large difference in initial BW between aged and young cows.
Effect of estradiol administration on hepatic GS content in aged cows
Evidence for estradiol-mediated regulation of GS expression continues to accumulate but is mixed. For example, estradiol is known to upregulate GS content and activity in cultured rat glial cells (Haghighat 2005) but not in cultured primary rat hepatocytes (Sirma et al. 1996) . In the human hypothalamus and hippocampus, estradiol increases GS expression and activity (Blutstein et al. 2006) . In cattle, findings from exploratory research conducted in our laboratory suggested that hepatic GS content is upregulated by SYNOVEX-S (20 mg 17β-estradiol benzoate + 200 mg progesterone) in finishing beef steers (Sipe 2004) . Furthermore, Miles et al. (2015) found that GS content was increased 350% by day 14 and 200% by day 28 in estradiol-administered vs. nonadministered aged cows of uncertain age, feed intake, and breed history.
To extend and elaborate these latter findings, the hypothesis tested using immunoblot analysis was that increased circulating estradiol (through estradiol administration) would increase hepatic content of GS in both young and aged cows (Table 2 ). For GS, there was an age effect (P = 0.02) but no TRT effect (P = 0.15), indicating that GS content was dependent on age but not estradiol administration. However, an estradiol treatment × experimental day interaction (P = 0.02) was observed. Subsequently, SLICE analysis (Table 2) found a significant TRT effect for day 16 (P = 0.02) but not day 28 (P = 0.79). Thus, estradiol administration affected GS protein content on day 16 but not day 28.
The second goal of this trial was to determine if estradiol administration affected GS transcription (Table 2) . Hepatic GS mRNA content tended to be increased (P = 0.07) by estradiol implant treatment. Although no age (P = 0.82) or day (P = 0.92) effect was found, an age × day interaction (P < 0.01) seems to reflect the lesser a Data are presented as least-squares means (n = 5-6) ± SEM for hormone concentrations of sham (control) and estradiol (estradiol, 25.7 mg 17β-estradiol) implant cows collected at 16 and 28 d after implantation. Most conservative error of the mean. c Overall P values: TRT = 0.03, day < 0.01, age = 0.34, TRT × day = 0.52, TRT × age = 0.473, age × day = 0.41, TRT × age × day = 0.45.
d Overall P values: TRT = 0.29, day = 0.31, age = 0.53, TRT × day = 0.38, TRT × age = 0.62, age × day = 0.45, TRT × age × day = 0.84. Overall P values: TRT = 0.76, day = 0.05, age = 0.57, TRT × day = 0.67, TRT × age = 0.78, age × day = 0.60, TRT × age × day = 0.49. Most conservative error of the mean. c Overall P values: TRT = 0.69, day < 0.01, age = <0.1, TRT × day = 0.16, TRT × age = 0.71, age × day = 0.55, TRT × age × day = 0.27.
d Overall P values: TRT = 0.06, age = 0.32, TRT × age = 0.14.
content of GS mRNA in young cows by day 28 vs. day 16 but increased GS mRNA content at day 28 than day 16 in aged cows. This understanding is supported by subsequent SLICE analysis that found a significant day effect for old cows (P = 0.03) and a tendency (P = 0.06) for a day effect on young cows. In summary, GS protein content was lower in aged than young cows and the d 16 stimulatory effect of estradiol on GS content appeared refractory (was not present by day 28). In contrast to GS protein content, GS mRNA expression tended to be affected by estradiol treatment, and aged and young cows had opposite temporal responses. Collectively, the incongruity between GS protein and mRNA content indicates that hepatic GS protein content was likely under posttranslational rather than pretranslational control.
Hepatic GPR30 and β-catenin content
The third goal of this experiment was to determine if estradiol effects on hepatic GS expression were concomitant with changes in β-catenin or GPR30 content. "Classical/genomic" estrogen-regulated cellular events are mediated by ERα, ERβ, and β-catenin. For this trial, we attempted to validate several commercial anti-ERα and ERβ antibodies for use in cow liver homogenates but were unsuccessful (data not shown). In contrast, we successfully validated the use of chicken anti-β-catenin ( Fig. 1) for use in cow liver. Although a direct relationship among estrogen, β-catenin, and GS expression in liver tissue has not been reported, the relative content of β-catenin has been used to describe activation of the β-catenin/Wnt pathway by sex steroid receptor in cattle skeletal muscle cells (Zhao et al. 2011 ). Accordingly, we tested the hypothesis that estradiol supplementation would increase hepatic expression of β-catenin in estradiol-supplemented young and aged cows by immunoblot analysis of liver homogenates (Table 2) . However, β-catenin expression was not affected (P ≥ 0.49) by TRT, age, or any interaction. β-Catenin was affected (P = 0.05) by experimental day, with increasing from day 16 to day 28.
The "nonclassical/nongenomic" estrogen-mediated pathway regulation of gene expression is through estradiol binding of GPR30 (Prossnitz and Barton 2011) . Although the GPR30 pathway is poorly understood, estrogen binding of GPR30 results in activation of several prominent secondary cellular cascades (adenylyl cyclase, phosphoinositol 3 kinase, phospholipase C, and protein kinase A; Thomas et al. 2005; Albanito et al. 2007; Heldring et al. 2007; Hsieh et al. 2007 ). Validation of an antihuman GPR30 antibody for use in bovine liver was successful (Fig. 2) , and the relative GPR30 protein content in liver homogenates was assessed by immunoblot analysis of liver homogenates. Although the bovine liver clearly expresses GPR30, no main or interaction TRT effects on GPR30 content were found for either aged or young cows (Table 2) . However, determination of whether the relative phosphorylation state of β-catenin was altered by estradiol administration awaits testing with antibovine antibodies capable of distinguishing the phosphorylation state of β-catenin.
As noted above, the mRNAs for ERα and ERβ are expressed in cattle liver (Pfaffl et al. 2001) , allowing for the possibility that estradiol administration to cattle stimulates GS expression through ERα-and ERβ-mediated pathways. However, development of antibovine ERα and ERβ antibodies will be necessary to evaluate this possibility and to investigate whether potential differences in hepatic ER content may explain differences in GS protein and mRNA content between young and aged cows. 0.520 µmol L -1
Conclusion
An important finding from this trial was that estradiol administration to young cows did not increase hepatic GS content, even though plasma estradiol levels were increased. In contrast, the hepatic GS content of aged cows was increased concomitant with increased plasma estradiol, thus identifying an age-dependent sensitivity to estradiol. Interestingly, for both young and aged cows, the magnitude of GS content in estradiol-treated cows was lower at day 28 than day 16, suggesting a transient ability to respond to estradiol administration. A second important finding was that GS mRNA content for old cows remained elevated at day 28, even though GS protein decreased. Thus, GS protein content may be more regulated by posttranscriptional than transcriptional events. The third salient finding was that neither the increased levels of circulating estradiol, nor the agerelated alteration of GS content, affected hepatic β-catenin or GPR30 content. However, whether these receptors were activated by either of these effects was not determined in the present study. Overall, the specific hypotheses that estradiol administration would increase hepatic GS content in young as well as aged cows and that putative changes in hepatic GS mRNA content will parallel protein content are rejected. In contrast, no conclusion can be drawn about whether an estradiolinduced increase in GS protein content would be accompanied by increased protein content of β-catenin, GPR30, or both, because the anticipated estradiol response was not apparent.
